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Background/aim: We aimed to investigate the role of Shearwave Elastography (SWE) in the evaluation of response to uterine artery
embolization (UAE) in patients with uterine leiomyomas.
Materials and methods: SWE images of the dominant uterin leiomyomas were obtained before and 1.5 months after performing UAE
in 33 women suffering from symptoms due to leiomyomas (menometrorrhagia, bulk related symptoms, pelvic pain). Leiomyomas were
also evaluated by 2 observers for location and longest diameter in axial plane. Interobserver agreement in the quantitative SWE analysis
was calculated using intraclass correlation coefficients.
Results: Thirty-three women (mean age, 39.7 years; range, 31–48 years) were examined with SWE 1.5 months after UAE. After treatment,
3 patients (9.1%) had fever, 1 patient had nausea and 29 patients (87.9%) had no complications. The post UAE stiffness measurements
of leiomyomas (mean SWE ± SD = 13.34 ± 3.9kPa) were significantly lower than the pre UAE measurements (mean SWE ± SD = 17.16
± 4.8kPa) (P < 0.001). There was excellent agreement between the 2 blinded observers in SWE measurements.
Conclusion: SWE values of leiomyomas after UAE significantly decreased. SWE, with its high reproducibility, could become a useful
tool in the follow up of uterin leiomyomas after UAE.
Key words: Sonoelastography, uterin artery embolization, uterine leiomyoma

1. Introduction
Uterine leiomyomas are the most common benign
tumor in the female pelvis affecting 20%–50% of women
[1]. The traditional treatment of uterine leiomyomas
is hysterectomy. About 1 in 3 women in the United
States is undergoing hysterectomy at the age of 60 [2].
Approximately 67% of hysterectomies in middle aged
women are performed due to uterine leiomyomas [3].
Although myomectomy is a less radical surgical technique
than hysterectomy, the recurrence of symptoms after
myomectomy (15–25% of cases) limits the use of this
technique [4,5]. Previously, uterine artery embolization
(UAE) was initiated prior to myomectomy [5], later UAE
was used as a treatment option for uterine leiomyomas
alone [6–13]. UAE is gaining popularity because it is a
safe, less invasive and cost effective way of treating uterin
leiomyomas causing bleeding, pain, pressure, and mass
effect [5–7,14,15].
In previous studies [16–20] ultrasonography (US)
and MRI were used to evaluate leiomyomas after UAE

treatment. Real-time Shearwave elastography (SWE) is a
new, highly reproducible, noninvasive imaging tool [21]
that measures the propagation speed of shear waves within
the tissue to locally quantify its stiffness quantitatively.
We aimed to measure uterin leiomyoma stiffness by
quantitative SWE before and after UAE and determine
whether SWE can be used in the evaluation of leiomyomas
after UAE.
2. Materials and methods
2.1. Study population and indications
The Local Ethics Committee of the Fatih Sultan Mehmet
Training and Research Hospital approved the study
and written informed consent was obtained from all
participants before inclusion in the study. Thirty-three
premenopausal women suffering from menometrorrhagia,
bulk-related symptoms, pelvic pain due to leiomyomas
treated by selective UAE were enrolled in this study. All
patients were informed of the possible risks and expected
benefits of the treatment and written informed consent
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was obtained from the patients. The mean age of the
patients was 39.7 years (range, 31–48). Transabdominal
gray scale US was performed to the pelvic region before
all patients were included in the study. All patients also
had pre- and postoperative contrast enhanced MRI. The
purpose of these imaging studies (US and MRI) was to
determine the location, number, and size of the uterine
leiomyomas and if there was any accompanying pathology
(adenomyosis, hydrosalpinx, malignancy), and identify
possible complications after the procedure. The patient
was not included in the study if there was pedunculated
subserosal leiomyoma (because tumor may separate
from the uterus and drift into the peritoneal cavity after
UAE). In addition, when submucosal leiomyomas were
pedunculated they were not included in the study because
they could break down to the endometrial cavity and
cause sepsis after cervical obstruction. If the submucosal
leiomyoma was single and appropriate for hysterescopic
resection, the patient was directed to resection. Also, if
there is any clinical finding of an infection in the genital
tract, leiomyoma is asymptomatic, or if there is a suspicion
of pregnancy, the patient was not included in the study.
2.2. Sonography and elastography technique
All US and SWE examinations were performed with a
convex 6 MHz frequency transducer (Toshiba, Aplio 500
Platinium, Japan). Transabdominal SWE measurements
of the leiomyomas were performed by 2 radiologists
after measuring the dimensions of the leiomyoma by
transabdominal gray scale US to the pelvic region before
embolization. These measurements were performed a few
days before UAE treatment and after an average of 44.2
days (39–54 days). Patients were taken after at least 4 h of
fasting. Even though more than 1 leiomyoma was present
in a patient, measurements and statistics were performed
on the dominant uterine leiomyoma. Both of the
radiologists were blinded to each other. The interobserver
agreement between these 2 radiologists was calculated.
All SWE measurements were performed while the patient
was lying in a supine position. To prevent the compression
effect of the probe, the operator placed the transducer
onto the skin surface and kept the transducer stationary
during the procedure. Measurements on elastography
were performed from transverse US images. The software
displayed both speed and propagation maps at dual mode.
The software also automatically provided an electronic box
which displayed tissue stiffness in a chromatic scale with
progression from blue to red, indicating low to high shear
modulus (stiffness). The integrated SWE software allowed
for placement of circular regions of interest (ROIs) within
the elastography window, and automatically displayed
shear modulus data (in kilopascals, kPa) for the ROIs. Each
radiologist performed 3 measurements with 2 mm ROIs at
approximately the same depth through the electronic box
and these 3 ROIs were averaged.

2.3. UAE procedure
Except 3 patients, all patients underwent bilateral
UAE under fluoroscopic control by using a biplane
angiographic system (Artis zee Biplane; Siemens, Erlangen,
Germany). Unilateral embolization was performed in
3 patients because one of the uterine arteries could not
be catheterized. All procedures were performed with
local anesthesia (prilocaine hydrochloride 1%, 10 cc).
Paracetamol infusion was performed prophylactically for
pain palliation. Bead Block (Bead Block; Biocompatibles,
Farnham, England) 500–700 μm was used in all patients
for embolization. Embolizing agent were suspended in
6–7 mL of normal saline and 6–7 mL of nonionic contrast
material. Stagnant flow with a pruned tree appearance and
no residual hypervascularization related to the leiomyomas
were the angiogenic end points for embolization (Figure).
There were no significant anastomoses between the uterine
and ovarian arteries, so no procedures were canceled.
2.4. Postembolization management and pain evaluation
All patients were hospitalized in the hospital on the evening
of the procedure. A 1 mg loading dose of morphine was
given to each patient before UAE. During and after the
procedure, 1 mg morphine was delivered every 7 min as
required, with a maximum dose of 12–15 mg every 4 h.
Nonsteroidal antiinflammatory drugs were also given to
patients intravenously during and after the procedure.
Approximately 5–6 h after the procedure, the patients
were asked to select one of the options: no pain, moderate,
or intense pain by asking their verbal scale of pain. All
patients except for 2 were kept under control for 24 h. One
patient stayed for 12 h because she wanted to go to home
at night, and 1 patient was discharged after a total of 48
h in the hospital because her pain was persistent. When
patients were discharged, nonsteroidal antiinflammatory
drugs were prescribed and they were advised to use them
if they experienced pain.
2.5. Statistical analysis
Statistical analyses were performed using the SPSS software
(version 16.0, SPSS Inc., Chicago, IL, USA). Quantitative
variables were expressed as mean ± standard deviation and
categorical variables as frequencies or percentages. The
mean elasticity and mean standard deviation within the
ROI are expressed as the mean of 3 different measurements.
Baseline data were evaluated using the Shapiro–Wilk test,
which showed that the elastography values were normally
distributed. Paired sample t tests were performed between
follow up, and the baseline reference SWE values assessed
differences in elastographic data. Statistical significance
was accepted at a P-value of less than 0.05. Interobserver
agreement in the quantitative analysis was calculated
using intraclass correlation coefficients (ICCs) from a one
way random effects model analysis of variance, with the
subject as the random effect. A 95% confidence interval
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Figure a. Uterine arteriogram obtained from 43-year-old woman with an uterine leiomyoma. Arrows outline the blood vessel supply of
the leiomyoma. b. View of the same uterine artery after uterine leiomyoma embolization. No distal flow is noted. (Curved arrow points
to catheter tip.) Ultrasound and shearwave elastography (SWE) images of the leiomyoma. c. before and d. 1.5 months after embolization.
There is a significant decrease in the SWE measurements of the leiomyoma after treatment. The vertical bar on the right shows the
elasticity range, the change in colors inside the box from dark blue to red indicates increasing stiffness.

(CI) was constructed for each ICC. An ICC greater
than 0.80 indicated excellent agreement. Correlations
between variables on patients were evaluated by Pearson’s
correlation coefficient value.
3. Results
There was 1 leiomyoma in 17 patients (51.5%), 2
leiomyomas in 15 patients (45.5%), and 3 leiomyomas in
1 patient (3%). All of the patients were premenopausal.
The largest leiomyoma of each patient was included in
the study. Of these dominant myomas, 15 (45.5%) were
subserose and 18 (54.5%) were intramural. 28 patients
(84.8%) had menorrhagia and 30 patients (90%) had
bleeding, pain, and pressure. A mean of 2.7 bottles
(minimum 1, maximum 6 bottles) of microspheres were
used during the UAE procedure.
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After UAE, 3 patients (9.1%) had fever, 1 patient had
nausea, and 29 patients (87.9%) had no complications.
Two patients with fever were treated with antibiotics. No
procedure was canceled due to a complication. All patients
except 3 were bilaterally embolized. In 3 patients (9.1%)
one of the uterine arteries could not be catheterized. There
was no uteroovarian anastomosis in any patient.
Patients who underwent bilateral UAE were compared
to those with unilateral UAE with student t test. Although
the rate of decrease in stiffness of the leiomyomas was
higher in bilateral embolized patients than that of the
unilateral ones (mean + SD; 22% ± 12 and 13% ± 0.3),
this difference was not statistically significant (P = 0.253).
After the procedure, 90.9% of the patients recovered from
the complaints and 3 patients (9.9%) did not fully recover
from bleeding, pain, and pressure.
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In Pearson’s correlation analyses preoperative
leiomyoma size, vials of PVA used (r = 0.87; P < 0.001),
and postembolization pain (r = 0.62; P < 0.01) were
significantly correlated. Also technical success (bilateral
UAE) was significantly correlated with relief from
symptoms (r = 0.63; P < 0.001) and menstrual bleeding
changes (r = 0.61; P < 0.001). Menstruel bleeding changes
after treatment are shown in Table 1.
Approximately 5–6 h after the treatment, patients
were asked about their pain verbally; 3 patients (9.1%)
experienced intense pain, 14 patients (42.4%) had
moderate pain, and 16 patients (48.5%) had no pain after
the procedure. No reintervention was made for UAE in
any patient.
The longest transverse dimensions of the leiomyomas
measured by US were 53.48 ± 15.2mm (range: 35–119)
before the procedure and 41.45 ± 12.2mm (range: 22–88)
1.5 months after the procedure. Compared with the paired
sample t test, leiomyoma size was reduced statistically
significantly (P < 0.001) (Table 2).
33 dominant leiomyomas in 33 patients were evaluated
by SWE with 2 different radiologists a few days before
UAE and an average of 44.2 days after the procedure
(39–54 days). The post UAE stiffness measurements of
leiomyomas (mean SWE ± SD = 13.34 ± 3.9kPa) were
significantly lower than the pre-UAE measurements (mean
SWE ± SD = 17.16 ± 4.8kPa) (P < 0.001) (Table 2). Figure
shows representative images of pre-UAE angiography,
the UAE procedure, and the pre- and post-UAE SWE
examinations. Interobserver variability results are shown
in Table 3. There was excellent agreement between the 2
blinded observers in SWE measurements.
4. Discussion
UAE is a new generation safe and cost effective treatment
method which has been used in the treatment of uterin
leiomyomas in recent years [6,22,23]. The aim of this
treatment is not only to reduce the size of the leiomyomas
but also to eliminate the pressure effect, reduce vascularity,
and relieve the patient’s complaints [20].
Since the principle of treatment is to occlude
micro-level vessels with particles, when evaluating the
treatment, it may not be enough to say that only the
size of the leiomyomas is reduced because the patient’s
complaints can be dramatically improved, although the
size of the leiomyoma does not decrease significantly
[19]. In our clinical practice, some patients showed
dramatic improvement in their complaints such as pain
and bleeding even though the leiomyoma size did not
shrink much. Therefore, instead of evaluating only the
size or vascularity of leiomyomas, we designed this
study by planning to evaluate the mechanical structure
of leiomyomas. Studies using US, Doppler US, and MRI

Table 1. Menstrual bleeding changes.
Change category

1.5 months

Complete resolution

25 (75.8%)

Significant improvement

6 (18.2%)

Slight improvement

1 (3%)

No change

1 (3%)

have already been published about patients undergoing
UAE therapy [15,17,19,24,25]. US and Doppler US allow
evaluation of the size and echogenicity of the leiomyomas
as well as vascularization. MRI examination shows the
pelvic organs, leiomyoma and uterus perfectly, but it is
quite costly especially when gadolinium is used [26].
SWE is a noninvasive and real-time imaging method
that measures the stiffness of the tissue. SWE has been
popular recently and has been used in many areas, mainly
thyroid and breast diseases [27–29]. The most important
advantage of SWE is that it is a quantitative, noninvasive
method that gives values in kpa [30]. Our aim was to
evaluate the feasibility and reproducibility of SWE for
showing the effects of UAE on the leiomyomas and assess
the value of SWE measurements as a new diagnostic
approach for evaluation of mechanical structure of
leiomyomas and change of tissue stiffness after uterin
leiomyoma treatment.
As we mentioned with more detail in the results
section, in our study, posttreatment elastography values
significantly decreased in patients after UAE compared
to pretreatment values (table 2). In order to understand
the pathophysiology of this decrease, it would be useful
to examine the studies on leiomyomas in which surgical
specimens were examined by the pathology after UAE was
performed.
McLucas et al. [31] examined leiomyomas
pathologically after UAE treatment with 500–700 mm
particles similar to ours. They observed diffuse ischemic
(coagulative) necrosis with interstitial edema which
causes separation of smooth muscle fibers and expansion
of interstitial compartment. Ischemic changes were
characterised by a loss of viability and architectural detail.
PVA particles occluded the vein, a foreign body giant cell
reaction developed against this synthetic material and
necrosis developed with this mechanism.
In a study by Cornelis et al. [32], in a patient, ischaemic
necrosis of the leiomyoma was seen 1 month after UAE.
They observed a hyaline necrosis of the arterial wall in an
ischaemic uterin leiomyoma surrounded by a chronically
inflamed myometrium, with very dilated blood vessels,
primarily veins. Subserosal arteries and a small vein were
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Table 2. Mean SWE values and longest diameters of uterin leiomyomas before UAE and 1.5 months
after UAE.
Before treatment
(n = 33)

After treatment
(n = 33)

P-value

SWE (mean ± SD)

17.16 ± 4.8 kPa

13.34 ± 3.9 kPa

<0.001*

Longest diameter in axial plane

53.48 ± 15.2 mm

41.45 ± 12.2 mm

<0.001*

SWE: Shearwave elastography
*Statistical comparison between gastric malignancies and benign gastric pathologies with paired
sample t-test.
Table 3. Interobserver variability for SWE measurements.

Mean SWE

Reader 1
(mean ± SD)

Reader 2
(mean ± SD)

ICC intraclass correlation
coefficient

Pretreatment SWE values (n =33)

17.16 ± 4.8 kPa

17.03 ± 4.7 kPa

0.988

(0.976–0.994)

Posttreatment SWE values (n = 33)

13.34 ± 3.9 kPa

13.64 ± 3.6 kPa

0.976

(0.952–0.988)

SWE: Shearwave elastography, ICC: Intraclass correlation coefficients, SD: standard deviation.

completely occluded by a lattice of embolic particles,
associated with an intense foreign body giant cell reaction.
As the elastography is a method of measuring the stiffness
of the tissue, the decrease in SWE values in the evaluation
performed after an average of 1.5 months can be explained
by the above-mentioned pathophysiological mechanisms
like ischemic (coagulative) necrosis.
Gordic et al. [33] evaluated hepatocellular
carcinomas (HCC) with MR elastography (MRE) after
radioembolization or transarterial chemoembolization
plus radiofrequency ablation. The results of their
preliminary study showed that treated HCCs had
significantly lower tumor stiffness compared to untreated
ones. Also, Li et al. [34] evaluated MRE derived stiffness in
human colorectal carcinoma cells, which were implanted
subcutaneously in the flanks of genetically modified mice.
MRE was performed before and 24 h after treatment
with either the vascular disrupting agent ZD6126 (N–
acetylcolchi– nol–O–phosphate) or vehicle control. No
significant changes were observed in the vehicle-treated
cohort. However, ZD6126 induced a significant decrease in
tumor stiffness and this was associated with histologically
confirmed central necrosis. These results are similar to our
study and show that histological cell death and reduction
in cellularity may change the mechanical properties of the
tissue and reduce the stiffness of the tissue. We looked
at the percentages of decrease in stiffness in SWE after
the UAE procedure in patients who said pressure effect
decreased and patients who said there was no relief in that
symptom. Stiffness reduction rate was 28.5% in the group
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that stated that the pressure effect decreased or passed, and
it was statistically significantly higher than the other group
(16.2%). This was probably the result of the reduction in
stiffness of the fibroid so less pressure on the bladder due
to possible mechanisms such as ischemic (coagulative)
necrosis with interstitial edema after UAE mentioned
above. The goal of embolization is the ischemic infarction
of the fibroid tumor, a result that is verifiable with follow
up imaging after embolization [16]. From a technical point
of view, failure of embolization occurs when the fibroid
tumor is not infarcted. In about 10% of treated patients,
no improvement of symptoms, which corresponds to
treatment failure, is observed [11].
In an MRI study [17], MRI showed a decrease in
leiomyoma size as in our study after 3 months from UAE. In
addition, increased signal on T1 weighted MR images and
decreased signal on T2 weighted MR images were observed
due to blood elements and hemorrhagic infarction. Of
course, if the measurements in our study were performed
6 months or 1 year after treatment, different results could
be obtained. For example, in a study by Goodwin et al.
[7], leiomyoma degeneration was seen histopathologically
in patients who underwent hysterectomy for treatment
failure at the 7th and 14th months. For this reason, the
mid–term and long–term results can be evaluated by new
studies conducted with larger patient groups and longer
intervals.
When we evaluated the interobserver agreement
in SWE measurements, we found that two observers
achieved highly compatible results with each other (Table
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3). This was very important in terms of demonstrating
the reproducibility of this method in the evaluation of
leiomyomas. Because SWE is a relatively more studied
method in superficial organs than in deeply located organs
[27–29].
In our study, the average size of leiomyomas showed
a statistically significant decrease after UAE as expected.
Leiomyoma size was evaluated in different studies in
patients treated with UAE; Tranquart et al. [19] observed
a 29% decrease in leiomyoma volume at 3 months after
UAE, 46% at 6 months, and 55% at 12 months. McLucas
et al. [20] reported 36% volume reduction in UAE after 1.5
months, 49% after 6 months, and 52% reduction after 12
months. As the months have passed, the size has gradually
decreased. Looking at these studies, we can say that as
the follow up period is longer, more size decreases are
expected.
In correlation analyses, leiomyoma size, vials of
PVA used, and postembolization pain were significantly
correlated. We have interpreted this data as more pain was
due to increased vials of the particle used because of the
large size of the leiomyoma. Likewise, as can be predicted,
there was a positive correlation between the ability to
catheterize 2 uterine arteries and the relief of complaints
and menstrual bleeding changes.
Although we showed the decrease in elastography
values after treatment in leiomyomas, in order to evaluate its
clinical reflection, we compared fully recovered menstrual
bleeding group with the other groups. The decrease in
elastography was significantly higher in the group whose
bleeding was completely normalized compared to those

whose bleeding did not change or slightly improved (P <
0.05). In other words, this change was evaluated not only
as numerically significant but also as a clinical reflection.
Our study had some limitations. As stated previously,
it would be better if several more follow ups were made
at longer intervals. We evaluated the dimensions with
the widest diameter; it would be better to calculate the
volume and make more objective size change analysis.
We did not analyze the results of some imaging methods
that could have been additionally performed, such as
Doppler ultrasonography and MRI. Although this issue
is important, the focus of this study was the assessment
of SWE for measuring the leiomyoma stiffness. The small
number of patients remains another limitation of this
study.
In conclusion, our study shows that the stiffness of
uterine leiomyomas decreases in SWE measurements
performed 1.5 months after UAE. SWE, with its high
reproducibility, could become a useful tool in the follow
up of uterin leiomyomas after UAE, in conjunction with
US and other imaging techniques. More data from more
patients and longer follow up times are needed to assess
the clinical relevance of our preliminary findings.
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